RxDoctor Payments Data

Melissa Lucado

Family · Bluefield, WVNPI 1164160867

Payments from drug & device makers

$4,055in general payments, 2019–2025

Across 215 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$629
  • Amgen$601
  • Lilly USA, LLC$489
  • AbbVie$474
  • Bayer$304
  • AstraZeneca$272
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$4,055100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,055 in reported general payments places this provider in the 90th percentile of 1,507 family providers in West Virginia.

See all family providers in West Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol57$55,154
TrulicityDulaglutide31$47,055
OzempicSemaglutide37$43,857
JardianceEmpagliflozin40$30,890
EliquisApixaban28$24,748
MounjaroTirzepatide21$21,844
KerendiaFinerenone20$18,473
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$16,533
XareltoRivaroxaban13$10,200
TradjentaLinagliptin12$8,350
LinzessLinaclotide11$6,879
Tresiba Flextouch U-100Insulin Degludec12$5,933
Breo ElliptaFluticasone/Vilanterol14$5,683
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$3,331
Albuterol Sulfate HfaAlbuterol Sulfate96$2,571

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$489$68,89952 claims
AstraZenecaFarxiga$272$55,15457 claims
Novo NordiskOzempic$629$43,85737 claims
Boehringer IngelheimJardiance, Tradjenta$43$39,24052 claims
PfizerEliquis$26$24,74828 claims
GSKTrelegy Ellipta, Breo Ellipta$244$22,21632 claims
BayerKerendia$304$18,47320 claims
AbbVieLinzess$474$6,87911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,507 family providers in West Virginia.

Other family in Bluefield

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →